Blueprint Medicines Corporation (BPMC)

$96.62 -3.25% $-3.25 Healthcare

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

$6.14B

Ms. Kathryn Haviland

602.00

Cambridge, MA

Apr 30, 2015

-46.23

$-2.09

0.35

3.32

-29.48%

-49.43

-3.91

20.21

14.60

3.27

-10.67%

-47.66%

Similar stocks (7)

Madrigal Pharmaceuticals, Inc.

MDGL

$339.04 -0.18%
Neutral

Krystal Biotech, Inc.

KRYS

$187.22 -4.42%
Uptrend

PTC Therapeutics, Inc.

PTCT

$44.08 -1.76%
Uptrend

Day One Biopharmaceuticals, Inc.

DAWN

$15.64 -1.39%
Neutral

Amylyx Pharmaceuticals, Inc.

AMLX

$6.24 -11.24%
Neutral

Inozyme Pharma, Inc.

INZY

$3.76 -6.00%
Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.68 -16.93%
Neutral

ETF Exposure (40)

Invesco Dynamic Biotechnology & Genome ETF

PBE

2.897%

$71.71 -0.73%
Uptrend

iShares Genomics Immunology and Healthcare ETF

IDNA

1.45787%

$24.71 -3.19%
Uptrend

American Century Focused Dynamic Growth ETF

FDG

1.21%

$102.87 0.34%
Uptrend

Direxion Daily S&P Biotech Bull 3X Shares

LABU

1.0937856214%

$131.90 -8.64%
Uptrend

BlackRock Future Health ETF

BMED

0.87076%

$26.22 -0.83%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.614%

$23.77 -2.42%
Uptrend

iShares Biotechnology ETF

IBB

0.5888%

$144.36 -2.27%
Uptrend

First Trust Nasdaq Pharmaceuticals ETF

FTXH

0.52%

$28.63 -1.62%
Uptrend

Global X Aging Population ETF

AGNG

0.49%

$31.78 -1.57%
Neutral

iShares Russell 2000 Growth ETF

IWO

0.42135%

$308.15 -1.74%
Uptrend

First Trust Active Factor Small Cap ETF

AFSM

0.35%

$32.67 -1.75%
Uptrend

John Hancock Multifactor Small Cap ETF

JHSC

0.34%

$42.61 -1.76%
Uptrend

First Trust Mid Cap Growth AlphaDEX Fund

FNY

0.29%

$85.84 -1.34%
Uptrend

Iq Candriam ESG U.S. Mid Cap Equity ETF

IQSM

0.28%

$34.32 -1.00%
Uptrend

iShares Morningstar Small-Cap Growth ETF

ISCG

0.23718%

$52.74 -1.35%
Uptrend

iShares Russell 2000 ETF

IWM

0.21539%

$237.36 -1.79%
Uptrend

AI Powered Equity ETF

AIEQ

0.21%

$40.53 -0.72%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.18374451167227326%

$62.76 -5.40%
Uptrend

Fidelity Small-Mid Factor ETF

FSMD

0.16%

$43.88 -1.13%
Uptrend

JPMorgan BetaBuilders U.S. Mid Cap Equity ETF

BBMC

0.15%

$101.51 -0.94%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.1487454976%

$27.60 -1.55%
Uptrend

iShares Morningstar Small-Cap ETF

ISCB

0.12361%

$62.50 -1.39%
Uptrend

Vanguard Small Cap Index Fund

NAESX

0.11%

$122.72 1.19%
Uptrend

First Trust Active Factor Mid Cap ETF

AFMC

0.1%

$33.96 -1.08%
Uptrend

Fidelity MSCI Health Care Index ETF

FHLC

0.08108154000000001%

$70.21 -1.45%
Neutral

First Trust Multi Cap Growth AlphaDEX Fund

FAD

0.08%

$145.89 -0.86%
Uptrend

iShares ESG Aware MSCI USA Small-Cap ETF

ESML

0.07742%

$44.63 -1.35%
Uptrend

First Trust Mid Cap Core AlphaDEX Fund

FNX

0.07%

$123.24 -1.34%
Uptrend

ProShares Hedge Replication ETF

HDG

0.033955940919052574%

$50.24 -0.58%
Uptrend

Invesco FTSE RAFI US 1500 Small-Mid ETF

PRFZ

0.031%

$44.25 -1.54%
Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0.02%

$75.82 -0.41%
Uptrend

iShares Dow Jones U.S. ETF

IYY

0.01096%

$146.02 -0.24%
Uptrend

iShares Russell 3000 ETF

IWV

0.01081%

$342.01 -0.45%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.01079%

$131.55 -0.45%
Uptrend

Schwab 1000 Index ETF

SCHK

0.0103887619%

$28.84 -0.55%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

0.0100725532%

$23.18 -0.56%
Uptrend

Vanguard ESG U.S. Stock ETF

ESGV

0.01%

$106.49 -0.25%
Uptrend

Goldman Sachs Future Health Care Equity ETF

GDOC

0%

$34.14 -1.01%
Downtrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$74.69 -1.67%
Uptrend

Goldman Sachs MarketBeta U.S. 1000 Equity ETF

GUSA

0%

$51.92 -0.24%
Uptrend